Wednesday's Health Briefing, Legal Battle Over Chemical Spill, FDA Approves Sickle Cell Therapies, Credit Bureau Reporting Changes

Good morning. It’s Wednesday, December 13, and here are the top stories as you begin your day. Union Pacific Railroad is facing a class action lawsuit over a chemical spill that occurred decades ago in Wichita, contaminating groundwater in the area. The U.S. Food and Drug Administration has approved two gene therapies for sickle cell disease, offering potential relief for patients aged 12 years and older.

Additionally, recent changes in credit bureau reporting are impacting credit scores for individuals with medical debt. While these changes have positive implications for many, it’s important to understand that they do not eliminate the underlying debt itself. Stay informed on these developments and more in today’s newsletter.